This metabolic shift is mediated by epigenetic mechanisms that up-regulate genes involved in hepatic lipogenesis such as PPARγ, very low-density lipoprotein receptor (VLDLR), and CD36, contributing to the onset of steatotic liver disease and intensifying the effects of metabolic syndrome [185,186]. This evidence concerns the gene PPARG and liver disorder.